One-third of the worldwide population is estimated to be infected with Mycobacterium tuberculosis, 9 million persons develop tuberculosis disease each year, and 2 million die of the disease annually [1, 2] . Although the incidence rate of tuberculosis has been decreasing in many parts of the world, current rates of decrease are not consistent with the World Health Organization's Global Plan to Stop TB target of 6% per year, and the target of eliminating tuberculosis by 2050 will not be achieved [2] . Currently proposed strategies to improve tuberculosis control include the targeting of interventions, such as active case finding in specific high-risk groups. It is therefore essential to identify and characterize the determinants of tuberculosis risk so that resources and interventions can be directed at those most likely to develop and transmit tuberculosis.
The global burden of diabetes mellitus (DM) is increasing; current prevalence is estimated at 285 million cases and is expected to reach 438 million cases per year by 2030 [3] . An estimated 70% of adults with DM currently live in low-and middle-income countries, and the greatest increases in rates of DM are predicted to occur in countries with developing economies [3] . Many of these regions are also high or moderate burden areas for tuberculosis. A better understanding of the relationship between DM and tuberculosis will be helpful in determining the most effective public health measures to curb the convergence of these epidemics.
Although multiple other studies have found an association between DM and tuberculosis, most of these have used a casecontrol design, and, therefore, few of these have diagnosed DM prospectively or incorporated data on DM disease severity or treatment [4] [5] [6] [7] . Because tuberculosis disease can lead to both transient hyperglycemia [8] and chronic weight loss, studies that assess tuberculosis disease and DM simultaneously may misestimate the prevalence of DM among those with active tuberculosis. In this study, we assessed and quantified the association between DM and tuberculosis prospectively, controlling for potential confounding factors, including sex, age, smoking, crowding, and socioeconomic status, and stratifying by DM severity.
METHODS
We linked a cross-sectional survey conducted in Taiwan in 2001, the National Health Interview Survey (NHIS), to longitudinal data captured in the Taiwan National Health Insurance (NHI) database and the death registry of the Taiwan Ministry of Health, to estimate the risk of tuberculosis among persons with DM [9] .
National Health Interview Survey
The National Health Research Institute and Bureau of Health Promotion of Taiwan conducted the NHIS from August 2001 through February 2002, measuring sociodemographic, behavioral, and health status through in-person interviews [10] . Of the 18 142 participants aged $12 years, 17 715 had $1 medical visit before December 2004 and consented to have their results linked to the NHI database.
NHI Database
Participation in the NHI program is compulsory in Taiwan, and 97% of the population was enrolled in 2001 [11] . The NHI database includes all outpatient visits, hospitalizations, dates, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, and inpatient and outpatient pharmacy records.
Measurement of DM
Data on DM included self-report from the NHIS, ICD-9-CM codes for DM (code 250) and/or complications of DM [12] , and prescriptions for DM medications as recorded in the NHI database. We used 2 definitions of DM: ''DM'' and ''treated DM.'' DM was defined as any of the following: self-report, $2 outpatient ICD-9-CM codes for DM, $1 inpatient ICD-9-CM code for DM, or DM medication (prescription for $28 days during the study period or $2 prescriptions) [13] [14] [15] [16] [17] . Treated DM required prescription for one of the following DM medications: acarbose, acetohexamide, buformin, chlorpropamide, glibornuride, gliclazide, glimepiride, glipizide, gliquidone, glyburide, insulin, metformin, nateglinide, pioglitazone, repaglinide, rosiglitazone, tolazamide, and tolbutamide. Although the use of metformin was included as a treatment for DM, a prescription for metformin alone was not sufficient for a diagnosis of DM, because a previous study showed that use of metformin as the only diabetes-specific medication misclassified DM in 80% of cases [15] . We also assessed the number of DM complications and the ICD-9-CM component of the Diabetes Complications Severity Index (DCSI), a scoring system of DM-based complications that is used to predict mortality and hospitalization [12] and includes retinopathy, nephropathy, neuropathy, cerebrovascular disease, cardiovascular disease, peripheral vascular disease, and metabolic disorder.
Measurement of Tuberculosis Disease
Participants were classified as having incident tuberculosis disease if all of the following criteria were present in the NHI database: (1) $1 medical visit during the follow-up period with an ICD-9-CM code for tuberculosis (codes 010-018); (2) a prescription for $2 antituberculosis medications for .28 days during the study period; and (3) no finding of a misdiagnosis of tuberculosis during the study period on the basis of later diagnosis of nontuberculosis mycobacterial infection, lung cancer, or tuberculosis infection without evidence of disease [9] .
Measurement of Covariates
We included the following NHIS variables previously identified as risk factors [18] for tuberculosis: sex, age, crowding, smoking, household income [19, 20] , marital status, education, alcohol use, residence in an indigenous community [20] , receipt of government subsidy, employment, lung disease, body mass index (BMI) (measured as the weight in kilograms divided by the square of the height in meters), hypertension, and heart disease.
Statistical Analysis
Participants contributed person-time from the date of their interview until the end of follow-up, death, or development of tuberculosis disease. We used Cox proportional hazards regression analysis to estimate the univariate and multivariate hazard ratios (HRs) for tuberculosis disease among those with DM and other baseline covariates. Markov Chain Monte Carlo methods were used to impute missing values of the covariates (SAS software, version 9.2; SAS Institute) [21] . Less than 0.1% of data on sex, age, crowding, smoking, employment, residence in an indigenous community, and marital status were missing. Data on 0.9% of household income, 0.4% of receipt of government subsidies, 0.1% of education, 0.2% of alcohol use, 10.6% of BMI, 1.2% of hypertension, and 1.5% of heart and lung disease were missing.
All covariates were included in the multivariate model. Age was modeled continuously on the basis of the likelihood ratio test for the optimal model, and other categorical covariates were modeled as indicator variables. We also performed a sensitivity analysis to assess the potential bias by loss to follow-up. In this analysis, we evaluated the HR with use of person-time from the date of interview until tuberculosis disease, death, or the last medical visit in the NHI records (from August 2001 through December 2004), rather than the end of follow-up in December 2004.
For the severity analysis, we assessed the number of complications and the DCSI score as indicator variables in the multivariate Cox proportional hazards regression analyses using the treated DM definition. We assessed the linear trend for severity by modeling the mean values of the categories as a continuous variable. All statistical tests were 2 sided with an a level of .05 and confidence intervals (CIs) of 95%; analyses were performed using SAS software, version 9.2 (SAS Institute).
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RESULTS
Among the 17 715 individuals included in the longitudinal cohort ( Table 1, Table 2 ), 9% were classified as having DM and 7% had treated DM. The median age was 37.91 years, and women were equally represented; 57% of the population was either married or cohabitating, 20% received government subsidies, 9% lived in households with $8 cohabitants, and 7% resided in an indigenous community. Twenty-two percent of the population smoked at the time of the interview, and 13% used alcohol regularly or heavily. Those with DM were older, had a higher BMI, and were more likely to have a low household income, receive government subsidies, be unemployed, be married or cohabitating, receive less schooling, and have hypertension, heart disease, and lung disease, compared with those without DM.
Tuberculosis disease occurred in 57 persons during the followup period (99.88 cases per 100 000 person-years); of these, 13 had a previous diagnosis of treated DM. The univariate HR for tuberculosis disease among those with a diagnosis of DM was 3.60 (95% CI, 1.99-6.48) and among those who had documentation of treated DM was 4.37 (95% CI, 2.35-8.12). Other covariates that were associated with tuberculosis disease in univariate analyses included age, low household income, receipt of government subsidies, employment status, residence in an indigenous community, marital status, education, smoking, alcohol use, lung disease, heart disease, and hypertension (Table 3) .
Both diabetes classifications remained significantly associated with tuberculosis disease after we adjusted for confounding factors. Among those with DM, the HR for tuberculosis was 2.09 (95% CI, 1.10-3.95), and among those with treated DM, the HR was 2.60 (95% CI, 1.34-5.03) ( Table 3 ). When we restricted our analysis to include only person-time that occurred before the last recorded medical visit, the HR for treated DM changed by ,10% to 2.51 (95% CI, 1.30-4.85). Because of the small number of exposed cases, we did not assess effect modification by age. The median age among those with treated DM was 60.25 years, compared with the median age of those without of 36.49 years. The median age of those with tuberculosis (61.41 years) was also higher than that of the general population.
The HR for tuberculosis disease among participants with treated DM, compared with those without, increased with increasing number of complications of DM and with increasing DCSI score ( Table 4 ). The adjusted HR was 1.73 (95% CI, .61-4.89) among participants with either no complications or 1 complication of DM and increased to 3.45 (95% CI, 1.59-7.50) among participants with $2 complications. Similarly, the HR increased from 1.72 (95% CI, .72-4.13) among those with a DCSI score ,4 to 5.05 (95% CI, 2.11-12.04) among those with a severity score $4. With both of these severity indices, we found a significant linear relationship with severity (P 5 .0016 and P 5 .0002, respectively).
DISCUSSION
In this prospective study of the risk of tuberculosis among persons with DM in Taiwan, we found that DM increases the hazard of developing tuberculosis disease with use of either of 2 different definitions of DM. A more stringent definition that included documentation of therapy yielded a higher HR (2.60), compared with a more inclusive definition (2.09). The risk increased markedly both by the number of diabetic complications experienced and by increasing score on the DCSI, a scale designed to predict mortality and risk of hospitalization [12] . Surprisingly, persons with DM in this national sample of Taiwanese persons shared a number of other risk factors for tuberculosis, including older age, unemployment, and low educational status, and thus the hazard in the univariate analysis was almost twice that in the multivariate analysis.
The finding that DM is a moderate risk factor for tuberculosis is consistent with findings in the prior literature and 2 metaanalyses supporting an association between DM and tuberculosis [4, 6, 7, [22] [23] [24] . The majority of these studies used a case-control design and a variety of control selection strategies [4, [25] [26] [27] . Of no surprise, odds ratios for the impact of DM on tuberculosis varied markedly; in a meta-analysis, they ranged from 1.16 to 7.83 and were found to depend on study quality variables and differences in the populations studied [4] . Of 4 prospective studies published to date, all showed relatively consistent effect estimates for DM with HRs or relative risks of 2.24 and 3.81 in 2 cohorts of renal transplant recipients [6, 22] , 1.77 among older residents of Hong Kong [24] , and 3.47 in an unadjusted analysis of tuberculosis risk among Korean civil servants [23] . In those studies that reported separate results for culture-confirmed tuberculosis, relative risks were always higher for this outcome than for tuberculosis diagnosed by less rigorous methods. Of note, ours is the only one of the prospective studies on DM and tuberculosis that both was conducted in a general population and controlled for a broad range of socioeconomic confounders.
Findings of other studies also support our finding that patients with more severe DM are at higher risk for tuberculosis [24, 28] . In these studies, disease severity was assessed in multiple ways, with some studies stratifying on the basis of insulin use as a proxy for DM severity, others using ICD-9-CM or other billing codes for complications, and others assessing hemoglobin A1c as a marker of medium-term glycemic control. Although these markers are not equivalent and are complicated by changing patterns of insulin and oral hypoglycemic drug use across different countries, most studies suggest a dose effect, and in one, persons with well-controlled DM (ie, with a hemoglobin A1c level ,7%) were actually at lower risk than were those without DM [24] . These findings may reflect the complex role that BMI plays in the etiology of tuberculosis susceptibility; although high BMI is a strong risk factor for DM, it has been shown in numerous studies to be an independent protective factor against tuberculosis [29, 30] . Consequently, the higher BMI in patients with wellcontrolled DM may, in fact, trump any risk for tuberculosis that results from mild hyperglycemia.
These findings underline the fact that the mechanisms by which DM increases susceptibility to tuberculosis (and, perhaps, other infectious diseases) are not yet well understood. Several early studies suggested that proinflammatory cytokines were reduced in mouse models of DM and in humans after infection with M. tuberculosis, whereas others reported cytokine responses that were biased toward a T-helper 2 phenotype [31, 32] . More recent studies have suggested that T-helper 1 type cytokines are upregulated in M. tuberculosis-infected mice with streptozotocininduced DM [33] and in humans with DM; in this latter study, Restrepo et al [34] observed increasing levels of proinflammatory cytokines with increasing levels of glycemia. Despite these findings, Vallerskog et al [35] noted an initial delay in the adaptive immune response, including the appearance of IFN-c-producing T cells, the dissemination of bacteria from lung to lymph nodes, and the aggregation of leukocytes at sites of infection. The investigators speculate that this delay may explain both the higher stationary bacterial loads observed in diabetic mice and the later increase in inflammatory cytokines [35] . We note several limitations of our study. First, DM was classified on the basis of self-report, ICD-9-CM codes, and pharmacy records; therefore, undiagnosed cases would not have been included. However, the 2 estimates that we obtained of the prevalence of DM, 9% and 7%, with use of the definition for DM and treated DM, respectively, were very similar to the estimated prevalence of 8.2% among men and 7.7% among women reported by Danaei et al [36] in a recent meta-analysis that required systematic biochemical assessment of DM among all members of representative cohorts. This concordance contrasts with the findings of the National Health and Nutrition Examination Survey and other similar surveys in the United States in which estimates of self-reported DM substantially underestimate the measured rates [37] . The finding that the prevalence of self-reported DM corresponds to the measured prevalence is consistent with prior evidence from Taiwan [38] and may reflect the unusual culture of medical care seeking in Taiwan, where the mean number of clinic visits per person per year is 13.4 [39] . Another limitation of our method was that we defined tuberculosis on the basis of ICD-9-CM codes and prescription history rather than microbiological data. Nondifferential misclassification of tuberculosis among those with DM might occur if providers are more likely to screen diabetic patients for active tuberculosis. Of note, we screened the NHI records of patients who received a diagnosis of tuberculosis on the basis of this definition, and patients who were found to have received a misdiagnosis were reclassified [9] . Furthermore, we did not have information on human immunodeficiency virus (HIV) infection in the study population and could not, therefore, control for this strong risk factor for tuberculosis disease. However, because prevalence of HIV infection in Taiwan was estimated to be ,0.02% at the end of 2003, we expect that confounding resulting from HIV infection would have little effect on our HRs [40] . Lastly, we were unable to adjust for some unmeasured risk factors, such as contact with known tuberculosis case patients, which may have mediated the association between DM and tuberculosis. In this prospective cohort study in a general population, we found that DM increases the risk of tuberculosis disease and that disease severity is associated with increasing risk. The increased risk of tuberculosis among individuals with DM, and particularly among those with complications due to DM, supports the notion that tuberculosis elimination efforts will need to include a focus on DM, an already prevalent condition that is expected to increase in many areas of high and moderate tuberculosis burden.
Notes

